These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 26760158)

  • 1. Markov Models in health care.
    Sato RC; Zouain DM
    Einstein (Sao Paulo); 2010 Sep; 8(3):376-9. PubMed ID: 26760158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical approach for evaluating Markov models in continuous time without discrete-event simulation.
    van Rosmalen J; Toy M; O'Mahony JF
    Med Decis Making; 2013 Aug; 33(6):767-79. PubMed ID: 23715464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3.
    Siebert U; Alagoz O; Bayoumi AM; Jahn B; Owens DK; Cohen DJ; Kuntz KM;
    Value Health; 2012; 15(6):812-20. PubMed ID: 22999130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A piecewise-homogeneous Markov chain process of lung transplantation.
    Sharples LD; Taylor GI; Faddy M
    J Epidemiol Biostat; 2001; 6(4):349-55. PubMed ID: 12036269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging methods in economic modeling of imaging costs and outcomes a short report on discrete event simulation.
    Hollingworth W; Spackman DE
    Acad Radiol; 2007 Apr; 14(4):406-10. PubMed ID: 17368208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis.
    Hiligsmann M; Ethgen O; Bruyère O; Richy F; Gathon HJ; Reginster JY
    Value Health; 2009; 12(5):687-96. PubMed ID: 19508659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling hard clinical end-point data in economic analyses.
    Kansal AR; Zheng Y; Palencia R; Ruffolo A; Hass B; Sorensen SV
    J Med Econ; 2013 Nov; 16(11):1327-43. PubMed ID: 24032651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding Events to a Markov Model Using DICE Simulation.
    Caro JJ; Möller J
    Med Decis Making; 2018 Feb; 38(2):235-245. PubMed ID: 28675959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete event simulation: the preferred technique for health economic evaluations?
    Caro JJ; Möller J; Getsios D
    Value Health; 2010 Dec; 13(8):1056-60. PubMed ID: 20825626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of spatio-temporal model to estimate burden of diseases, injuries and risk factors in Iran 1990 - 2013.
    Parsaeian M; Farzadfar F; Zeraati H; Mahmoudi M; Rahimighazikalayeh G; Navidi I; Niakan Kalhori SR; Mohammad K; Jafari Khaledi M
    Arch Iran Med; 2014 Jan; 17(1):28-33. PubMed ID: 24444062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost utility analysis of endoscopic biliary stent in unresectable hilar cholangiocarcinoma: decision analytic modeling approach.
    Sangchan A; Chaiyakunapruk N; Supakankunti S; Pugkhem A; Mairiang P
    Hepatogastroenterology; 2014; 61(133):1175-81. PubMed ID: 25436278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling disease-state transition heterogeneity through Bayesian variable selection.
    Healy BC; Engler D
    Stat Med; 2009 Apr; 28(9):1353-68. PubMed ID: 19206077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision analysis and Markov modeling in urology.
    Hsieh MH; Meng MV
    J Urol; 2007 Nov; 178(5):1867-74. PubMed ID: 17868735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous time version and a generalization of a Markov-recapture model for trapping experiments.
    Alpizar-Jara R; Smith CE
    Math Biosci; 2008; 214(1-2):11-9. PubMed ID: 18556026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrete Markov image modeling and inference on the quadtree.
    Laferté JM; Pérez P; Heitz F
    IEEE Trans Image Process; 2000; 9(3):390-404. PubMed ID: 18255411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markov transition models for binary repeated measures with ignorable and nonignorable missing values.
    Xiaowei Yang ; Shoptaw S; Kun Nie ; Juanmei Liu ; Belin TR
    Stat Methods Med Res; 2007 Aug; 16(4):347-64. PubMed ID: 17715161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and Rationality in Adolescent Decision Making: Implications for Theory, Practice, and Public Policy.
    Reyna VF; Farley F
    Psychol Sci Public Interest; 2006 Sep; 7(1):1-44. PubMed ID: 26158695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.